Literature DB >> 5672814

Metabolism of drugs. LIX. A new metabolite of antipyrine.

H Yoshimura, H Shimeno, H Tsukamoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5672814     DOI: 10.1016/0006-2952(68)90210-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  18 in total

1.  Effect of deltamethrin on antipyrine pharmacokinetics and metabolism in rat.

Authors:  A Anadón; M R Martinez-Larrañaga; M J Díaz; P Bringas; M C Fernandez
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

Review 2.  Factors influencing antipyrine elimination.

Authors:  I H Stevenson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

3.  Gas chromatographic assessment of the reproducibility of phenazone plasma half-life in young healthy volunteers.

Authors:  S Lindgren; P Collste; B Norlander; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

Review 4.  Assessment of the drug metabolism capacity of the liver.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

5.  Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.

Authors:  M Danhof; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

Review 6.  Assessment of methods to identify sources of interindividual pharmacokinetic variations.

Authors:  E S Vesell; M B Penno
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

7.  Monogenic control of variations in antipyrine metabolite formation. New polymorphism of hepatic drug oxidation.

Authors:  M B Penno; E S Vesell
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

8.  Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism.

Authors:  W D Paton; R G Pertwee
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

9.  Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery.

Authors:  N Buchanan; M Davis; M Danhof; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

10.  Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat.

Authors:  D J Back; F Sutcliffe; J F Tjia
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.